CAI ZELING has a total of 16 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are TRANSGENE SA, 1GLOBE HEALTH INST LLC and WELLSTAT OPHTHALMICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | China | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Cai Zeling | 16 |
#2 | Shi Wei-Xing | 12 |
#3 | Degraw Juli | 8 |
#4 | Peterson Per A | 7 |
#5 | Kong Yan | 7 |
#6 | Jackson Michael R | 7 |
#7 | Liu Xuejun P | 4 |
#8 | Wu Jiejun | 4 |
#9 | Chen Yi | 4 |
#10 | Moriarty Ann | 1 |
Publication | Filing date | Title |
---|---|---|
CN107406504A | Antibody of CTLA 4 and application thereof | |
US2011070185A1 | Identification of antigenic peptides from multiple myeloma cells |